Penn Medicine has established a new telemedicine pilot program that will offer second opinions to patients diagnosed with brain tumors.
The first phase of the program is designed to extend the reach of and access to specialists at the Penn Brain Tumor Center who are focused solely on the diagnosis and treatment of benign and malignant brain tumors.
Dr. Steven Brem, the co-director of the Brain Tumor Center and director of neurosurgical oncology at Penn, called receiving a brain tumor diagnosis…